Clinical Trials List
2007-05-01 - 2009-12-31
Phase III
Study ended11
ICD-10M32.0
Drug-induced systemic lupus erythematosus
ICD-10M32.10
Systemic lupus erythematosus, organ or system involvement unspecified
ICD-10M32.11
Endocarditis in systemic lupus erythematosus
ICD-10M32.12
Pericarditis in systemic lupus erythematosus
ICD-10M32.13
Lung involvement in systemic lupus erythematosus
ICD-10M32.14
Glomerular disease in systemic lupus erythematosus
ICD-10M32.15
Tubulo-interstitial nephropathy in systemic lupus erythematosus
ICD-10M32.19
Other organ or system involvement in systemic lupus erythematosus
ICD-10M32.8
Other forms of systemic lupus erythematosus
ICD-10M32.9
Systemic lupus erythematosus, unspecified
ICD-9710.0
Systemic lupus erythematosus
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chen Der-Yuan Division of Rheumatology
- Yi-Hsing Chen Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- 謝祖怡 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 陳基益 Division of Rheumatology
- Chang-Fu Kuo Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- Po-Hao Huang Division of Rheumatology
- 黃麗雪 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 歐燦騰 風濕免疫科
- Jeng-Hsien Yen Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 童建學 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- SONG-CHOU HSIEH 風濕免疫科
- CHENG-HAN WU 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Study ended
The Actual Total Number of Participants Enrolled
0 Study ended
Co-Principal Investigator
- 楊宗翰 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
110 participants
-
Global
810 participants
